Skip to content

Bridging the transition from hospital to home: Effects of the VITAL Telehealth Program on recovery for CABG patients and their caregivers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN77474147
Enrollment
174
Registered
2005-09-13
Start date
2005-01-03
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recovery from coronary artery bypass graft surgery Surgery Coronary artery bypass graft surgery

Interventions

Participants are randomly assigned to receive usual follow-up care or follow-up care with telehealth equipment. Patients and their caregivers in both groups receive all the usual cardiac teaching that

Sponsors

McGill University (Canada)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patient is undergoing first-time CABG surgery 2. The patient is hospitalized and waiting for CABG surgery, or is admitted to hospital for surgery after being on the cardiac wait list 3. There is a caregiver available and present on admission and/or during the patient?s hospitalization 4. There is a telephone in the home 5. There is a grounded electrical outlet, or three-prong plug outlet, in the home 6. The patient and caregiver speak and understand English and are cognitively able to participate in the interviews 7. Both the patient and caregiver will be likely to be able to adhere with the VITAL program 8. The patient and caregiver both consent to participate

Exclusion criteria

Exclusion criteria: 1. Patient is scheduled for valve replacement surgery 2. An attending physician believes it is necessary for a patient to have the VITAL program upon discharge.

Design outcomes

Primary

MeasureTime frame
The 20-item State Anxiety Inventory (S-STAI) administered by telephone pre-operatively at baseline and at 5 days and 3 weeks after discharge

Secondary

MeasureTime frame
1. Center for Epidemiologic Studies Depression Scale -10 (CESD-10) administered pre-operatively at baseline and at 5 days and 3 weeks after discharge 2. Health Care Utilization data collected at 5 days and 3 weeks after discharge

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026